M
10b5-1 Plan
$ Value
$42K
Shares
9,999
Price
$4
Filed
Oct 30
Insider
Name
Meyer Andrew Hollman
Title
Chief Business Officer
CIK
0001864159
Roles
Officer
Transaction Details
Transaction Date
2025-10-28
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
92,138
Footnotes
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024. | The weighted average sale price for the transaction reported was $30.0622 and the range of prices were between $30.00 and $30.49. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | Immediately exercisable.
Filing Info
Meyer Andrew Hollman's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-02 | JANX | ▼ | $26K |
| 2025-12-01 | JANX | M | $35K |
| 2025-12-01 | JANX | ▼ | $89K |
| 2025-12-01 | JANX | ▼ | $21K |
| 2025-12-01 | JANX | M | $0 |
| 2025-11-14 | JANX | M | $35K |
| 2025-11-14 | JANX | ▼ | $100K |
| 2025-11-14 | JANX | M | $0 |
| 2025-10-28 | JANX | M | $42K |
| 2025-10-28 | JANX | M | $71K |
Other Insiders at JANX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Go William
Chief Medical Officer
|
— | — | 2026-02-02 |